An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

  1. Krolewiecki, A.
  2. Enbiale, W.
  3. Gandasegui, J.
  4. van Lieshout, L.
  5. Kepha, S.
  6. Messa Junior, A.
  7. Bengtson, M.
  8. Gelaye, W.
  9. Escola, V.
  10. Martinez-Valladares, M.
  11. Cambra-Pellejà, M.
  12. Algorta, J.
  13. Martí-Soler, H.
  14. Fleitas, P.
  15. Ballester, M.R.
  16. Doyle, S.R.
  17. Williams, N.A.
  18. Legarda, A.
  19. Mandomando, I.
  20. Mwandawiro, C.
  21. Muñoz, J.
Zeitschrift:
Gates Open Research

ISSN: 2572-4754

Datum der Publikation: 2022

Ausgabe: 6

Art: Artikel

DOI: 10.12688/GATESOPENRES.13615.1 GOOGLE SCHOLAR lock_openOpen Access editor

Ziele für nachhaltige Entwicklung

Datenquelle: Scopus